Gastroenterology CE Activities

Explore how the IBD CDST can help you with treatment selection.

Non-accredited

Gastroenterology blog

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.

Gastroenterology
Blog

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

Gastroenterology
Blog

RMEI Presentations

Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease (ACG)

An Inflammatory Bowel Disease (IBD) Decision Support Tool Predicts Drug Specific Remission and Improves Provider Mastery in Treatment Selection

Multi-Year Education Facilitated the Clinical Implementation of a Novel Point-of-Care Tool

How Education Facilitated Uptake of a Novel Point of Care Decision Aid in IBD: The IBD Clinical Decision Support Tool

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

When the Patient Voice is Heard in Education, Does the Clinician Listen?

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

Latest Gastroentrology Articles

Helicobacter pylori Infection — Advances, Challenges, and the Road Ahead October 22, 2026
The discovery of H. pylori has advanced the prevention and treatment of gastritis, peptic ulcers, and gastric cancer. Progress has been made in the research of H. pylori infection. These advances are discussed in this review.
Hong Li, Francis Megraud, Barry J. Marshall
Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea October 21, 2026
In two trials involving participants with OSA and obesity or overweight with or without type 2 diabetes, treatment with retatrutide was found to result in greater decreases in the apnea–hypopnea index than placebo.
Ronald R. Grunstein, Virend K. Somers, Ali Azarbarzin, Atul Malhotra, Scott A. Sands, Brendan P. Lucey, Sheryl E. Allen, Kathryn Giblin, Beverly L. Falcon, So Young Park, Jitong Lou, Kathryn Krueger, the TRIUMPH-1-OSA and TRIUMPH-2-OSA Investigators*
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis October 15, 2026
In a phase 2 trial of once-daily oral icotrokinra for moderately to severely active ulcerative colitis, a clinical response at week 12 was more common with icotrokinra at each of three tested doses than with placebo.
Maria T. Abreu, Britta Siegmund, Lindsey Surace, Ngozi Erondu, Minhu Chen, Karen Chachu, Edouard Louis, Katsuyoshi Matsuoka, Jimmy Limdi, Edmund Arthur, Nicole Houck, Colleen Marano, Marion L. Vetter, Bin Zou, Joyce Zhan, Mary Ellen Frustaci, Arun K. Kannan, Grazyna Rydzewska, Edward V. Loftus Jr., Vipul Jairath, the ANTHEM-UC Study Group*

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.